XML 43 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments
12 Months Ended
Jul. 31, 2014
Commitments [Abstract]  
Commitments
  10. Commitments

 

On July 17, 2013, the Company entered into a three year consulting agreement for consulting and advisory services related to the development of the Company's treatment to reverse opioid overdoses. In exchange for these services, the Company has agreed to pay the consultant 5.0% of the net profit generated from the product as related to the Company's treatment to reverse opioid overdoses. Net profit is defined as the pre-tax profit generated from the product after the deduction of all expenses incurred by and payments made by the Company in connection with the product, including but not limited to an allocation of Company overhead. If the product is not introduced to the market and not approved for marketing within 24 months the consultant will have a sixty day option to receive 6,250,000 shares of common stock in lieu of the 5.0% interest in the product.